Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Bone Marrow Transplantation|December 15, 2010
Long-term follow-up of a pilot study using a chemotherapy-alone protocol for killer Ig-like receptor-ligand-mismatched haploidentical haematopoietic SCTA P Schwarer, G Bollard, M Kapuscinski, et al.Transplantation|May 1, 1992
Evidence that umbilical cord blood contains a higher frequency of HLA class II-specific alloreactive T cells than adult peripheral blood. A limiting dilution analysisS J Deacock, A P Schwarer, J Bridge, et al.Cytotherapy|April 16, 2002
Flow cytometric quantitation and characterization of the T-lymphocyte memory response to CMV in healthy donorsN Hensel, J J Melenhorst, K Bradstock, et al.Bone Marrow Transplantation|June 28, 2005
Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimenM A Dawson, A P Schwarer, J L Muirhead, et al.Bone Marrow Transplantation|October 2, 2003
Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxisB P Howden, A Michaelides, D W Spelman, et al.British Journal of Haematology|January 1, 1992
Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioningJ O Cullis, A P Schwarer, T P Hughes, et al.Mycoses|March 31, 2007
Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin AC O Morrissey, M A Slavin, M A O'Reilly, et al.Bone Marrow Transplantation|May 1, 2007
A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantationM A Slavin, A P Grigg, A P Schwarer, et al.Internal Medicine Journal|March 20, 2004
Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantationJ Szer, S Durrant, A P Schwarer, et al.The Journal of Clinical Endocrinology and Metabolism|July 13, 2006
Pamidronate reduces bone loss after allogeneic stem cell transplantationA P Grigg, P Shuttleworth, J Reynolds, et al.Pageof 5